Biological Products, (No Diagnostic Substances) · DE · CIK 1812364
Relay Therapeutics transforms drug discovery with its Dynamo platform to create life-changing therapies for patients
Comparable business profile · signals at a glance
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 9, 2026: 4 sold $903K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Catinazzo ThomasChief Financial Officer | Sell | 17,717 | $10.06 | $178K |
| Jan 28, 2026 | Bergstrom Donald APresident, R&D | Sell | 2,686 | $8.45 | $23K |
| Jan 28, 2026 | Catinazzo ThomasChief Financial Officer | Sell | 1,695 | $8.45 | $14K |
| Jan 28, 2026 | Rahmer PeterSee remarks | Sell | 1,354 | $8.45 | $11K |
| Jan 27, 2026 | Bergstrom Donald APresident, R&D | Sell | 18,895 | $7.62 | $144K |
| Jan 27, 2026 | Catinazzo ThomasChief Financial Officer | Sell | 13,820 | $7.62 | $105K |
| Jan 27, 2026 | Rahmer PeterSee remarks | Sell | 11,684 | $7.62 | $89K |
| Jan 6, 2026 | Patel SanjivPresident and CEO | Sell | 43,168 | $7.82 | $338K |
| Nov 3, 2025 | Patel SanjivPresident and CEO | Sell | 62,073 | $7.00 | $435K |
| Oct 29, 2025 | Rahmer PeterSee remarks | Sell | 21,394 | $7.50 | $160K |
| Oct 28, 2025 | Bergstrom Donald APresident, R&D | Sell | 30,897 | $7.29 | $225K |
| Oct 28, 2025 | Catinazzo ThomasChief Financial Officer | Sell | 21,664 | $7.29 | $158K |
| Oct 28, 2025 | Rahmer PeterSee remarks | Sell | 19,135 | $7.29 | $139K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.